Full Text of the Letter from FDA of DOH Containing the "List of Prescription Drugs and Medicines for Diabetes, High-Cholesterol and Hypertension Exempt from VAT Beginning January 27, 2020"

June 8, 2020REVENUE MEMORANDUM CIRCULAR NO. 062-20SUBJECT : Publishing the Full Text of the Letter from the Food and Drug Administration (FDA) of the Department of Health (DOH) Containing the "List of Prescription Drugs and Medicines for Diabetes, High-Cholesterol and Hypertension Exempt from VAT Beginning January 27, 2020" Pursuant to Section 1 of Republic Act No. 11467   TO : All Internal Revenue Officials, Employees and Others Concerned For the information and guidance of all internal revenue officers, employees and others concerned, attached is the letter dated March 2, 2020 from Rolando Enrique D. Domingo, Undersecretary of Health and Officer-In-Charge (OIC) Director General of FDA, and the copy of the "List of Prescription Drugs and Medicines for Diabetes, High-Cholesterol and Hypertension Exempt from VAT beginning January 27, 2020." All concerned are hereby enjoined to be guided accordingly and give this Circular as wide a publicity as possible.(SGD.) CAESAR R. DULAYCommissioner of Internal RevenueATTACHMENTRepublic of the PhilippinesDepartment of HealthFood and Drug AdministrationMarch 2, 2020USEC. KARL KENDRICK T. CHUAUndersecretaryDEPARTMENT OF FINANCEDOF Bldg. BSP Complex,Roxas Boulevard, Malate, ManilaATTENTION :...